iMD Companies, Inc. (ICBU)
USD 0.0
(-4.44%)
USD 0.0
(-4.44%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 190.13 Thousand USD | -19.63% |
| 2022 | 236.56 Thousand USD | -46.68% |
| 2021 | 443.67 Thousand USD | -92.99% |
| 2020 | 6.32 Million USD | 0.08% |
| 2019 | 6.32 Million USD | -0.01% |
| 2018 | 6.32 Million USD | -73.17% |
| 2017 | 23.56 Million USD | -8.11% |
| 2016 | 25.64 Million USD | 8148.4% |
| 2015 | 310.91 Thousand USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 163.32 Thousand USD | -5.05% |
| 2024 Q1 | 172.01 Thousand USD | -9.53% |
| 2023 FY | 190.13 Thousand USD | -19.63% |
| 2023 Q4 | 190.13 Thousand USD | -5.75% |
| 2023 Q1 | 219.34 Thousand USD | -7.28% |
| 2023 Q2 | 205.96 Thousand USD | -6.1% |
| 2023 Q3 | 201.74 Thousand USD | -2.05% |
| 2022 Q1 | 249.57 Thousand USD | -43.75% |
| 2022 FY | 236.56 Thousand USD | -46.68% |
| 2022 Q4 | 236.56 Thousand USD | -4.07% |
| 2022 Q2 | 257.02 Thousand USD | 2.99% |
| 2022 Q3 | 246.59 Thousand USD | -4.06% |
| 2021 Q2 | 6.55 Million USD | 2.85% |
| 2021 FY | 443.67 Thousand USD | -92.99% |
| 2021 Q1 | 6.37 Million USD | 0.0% |
| 2021 Q4 | 443.67 Thousand USD | 64.52% |
| 2021 Q3 | 269.67 Thousand USD | -95.89% |
| 2020 FY | 6.32 Million USD | 0.08% |
| 2019 FY | 6.32 Million USD | -0.01% |
| 2018 FY | 6.32 Million USD | -73.17% |
| 2017 FY | 23.56 Million USD | -8.11% |
| 2016 FY | 25.64 Million USD | 8148.4% |
| 2015 FY | 310.91 Thousand USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| American Bio Medica Corporation | 1.26 Million USD | 85.017% |
| Arrayit Corporation | 1 Million USD | 80.994% |
| Atlantic International Corp. | 4.43 Million USD | 95.714% |
| Biocept, Inc. | 30.87 Million USD | 99.384% |
| Bioqual, Inc. | 56.58 Million USD | 99.664% |
| CardioGenics Holdings Inc | 231.93 Thousand USD | 18.02% |
| DermTech, Inc. | 121.93 Million USD | 99.844% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 4.18 Billion USD | 99.995% |
| HTG Molecular Diagnostics, Inc. | 17.77 Million USD | 98.93% |
| IDenta Corp. | 1.52 Million USD | 87.567% |
| Interpace Biosciences, Inc. | 13.02 Million USD | 98.54% |
| Integrative Health Technologies, Inc. | 8.25 Million USD | 97.696% |
| InVitro International | 1.53 Million USD | 87.605% |
| Lumos Diagnostics Holdings Limited | 26.83 Million USD | 99.292% |
| Many Bright Ideas Technologies Inc. | 2312.00 USD | -8123.919% |
| Medical Imaging Corp. | 4.19 Million USD | 95.464% |
| NovelStem International Corp. | 2.25 Million USD | 91.567% |
| Optigenex Inc. | 1.88 Million USD | 89.931% |
| PharmChem, Inc. | 2.76 Million USD | 93.125% |
| Proteome Sciences plc | 14.58 Million USD | 98.696% |
| Response Genetics, Inc | 48.88 Million USD | 99.611% |
| Rennova Health, Inc. | 20.57 Million USD | 99.076% |
| RushNet, Inc. | 6.04 Million USD | 96.856% |
| ScreenPro Security Inc. | 1.26 Million USD | 84.926% |
| Stella Diagnostics Inc. | 472.42 Thousand USD | 59.753% |
| StageZero Life Sciences Ltd. | 700.65 Thousand USD | 72.863% |
| Todos Medical Ltd. | 15.26 Million USD | 98.755% |